359 related articles for article (PubMed ID: 29545328)
21. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
23. Impact of "a" determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B.
Huang X; Ma C; Zhang Q; Shi Q; Huang T; Liu C; Li J; Hollinger FB
J Med Virol; 2017 Oct; 89(10):1796-1803. PubMed ID: 28513915
[TBL] [Abstract][Full Text] [Related]
24. The association of the hepatitis B virus infection and diffuse large B-cell lymphoma.
Yu G; Han J; Xu J
Saudi Med J; 2024 May; 45(5):490-494. PubMed ID: 38734435
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers.
Wei XL; Luo HY; Li CF; Jin Y; Zeng ZL; Ju HQ; Wu QN; Wang Y; Mao MJ; Liu WL; Jia WH; Zhang HZ; Li YH; Wang F; Xu RH
Int J Cancer; 2017 Jul; 141(1):152-159. PubMed ID: 28369849
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
27. Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.
Zurawska U; Hicks LK; Woo G; Bell CM; Krahn M; Chan KK; Feld JJ
J Clin Oncol; 2012 Sep; 30(26):3167-73. PubMed ID: 22711851
[TBL] [Abstract][Full Text] [Related]
28. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.
Chu CM; Yeh CT; Liaw YF
J Clin Microbiol; 1998 Jul; 36(7):2084-6. PubMed ID: 9650968
[TBL] [Abstract][Full Text] [Related]
29. Occult hepatitis B virus infection.
Raimondo G; Pollicino T; Cacciola I; Squadrito G
J Hepatol; 2007 Jan; 46(1):160-70. PubMed ID: 17112622
[TBL] [Abstract][Full Text] [Related]
30. Molecular epidemiological study of hepatitis B virus genotypes in Southwest, China.
Shen L; Yin W; Zheng H; Cui F; Zhang S; Wang F; Wang F; Zhang Y; Liang X; Bi S
J Med Virol; 2014 Aug; 86(8):1307-13. PubMed ID: 24797477
[TBL] [Abstract][Full Text] [Related]
31. [Natural history of hepatitis B infection].
Pol S
Presse Med; 2006 Feb; 35(2 Pt 2):308-16. PubMed ID: 16493335
[TBL] [Abstract][Full Text] [Related]
32. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.
Yeo W; Chan PK; Zhong S; Ho WM; Steinberg JL; Tam JS; Hui P; Leung NW; Zee B; Johnson PJ
J Med Virol; 2000 Nov; 62(3):299-307. PubMed ID: 11055239
[TBL] [Abstract][Full Text] [Related]
33. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
34. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
35. Existence of hepatitis B virus surface protein mutations and other variants: demand for hepatitis B infection control in Cambodia.
Ko K; Takahashi K; Nagashima S; Yamamoto C; Ork V; Sugiyama A; Akita T; Ohisa M; Chuon C; Hossain MS; Mao B; Tanaka J
BMC Infect Dis; 2020 Apr; 20(1):305. PubMed ID: 32334529
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
[TBL] [Abstract][Full Text] [Related]
38. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
Dalia S; Chavez J; Castillo JJ; Sokol L
Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055
[TBL] [Abstract][Full Text] [Related]
40. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
